SG11201601807XA - Methods for treating chronic obstructive pulmonary disease using benralizumab - Google Patents
Methods for treating chronic obstructive pulmonary disease using benralizumabInfo
- Publication number
- SG11201601807XA SG11201601807XA SG11201601807XA SG11201601807XA SG11201601807XA SG 11201601807X A SG11201601807X A SG 11201601807XA SG 11201601807X A SG11201601807X A SG 11201601807XA SG 11201601807X A SG11201601807X A SG 11201601807XA SG 11201601807X A SG11201601807X A SG 11201601807XA
- Authority
- SG
- Singapore
- Prior art keywords
- benralizumab
- methods
- pulmonary disease
- chronic obstructive
- obstructive pulmonary
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361891175P | 2013-10-15 | 2013-10-15 | |
| US201461970126P | 2014-03-25 | 2014-03-25 | |
| PCT/US2014/060432 WO2015057668A1 (en) | 2013-10-15 | 2014-10-14 | Methods for treating chronic obstructive pulmonary disease using benralizumab |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201601807XA true SG11201601807XA (en) | 2016-04-28 |
Family
ID=52809872
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201601807XA SG11201601807XA (en) | 2013-10-15 | 2014-10-14 | Methods for treating chronic obstructive pulmonary disease using benralizumab |
| SG10201807318RA SG10201807318RA (en) | 2013-10-15 | 2014-10-14 | Methods for treating chronic obstructive pulmonary disease using benralizumab |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201807318RA SG10201807318RA (en) | 2013-10-15 | 2014-10-14 | Methods for treating chronic obstructive pulmonary disease using benralizumab |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US20150104447A1 (https=) |
| EP (2) | EP3485902A1 (https=) |
| JP (3) | JP2016534996A (https=) |
| KR (1) | KR20160061352A (https=) |
| CN (2) | CN105636607A (https=) |
| AU (2) | AU2014334563A1 (https=) |
| BR (1) | BR112016008082A2 (https=) |
| CA (1) | CA2925402A1 (https=) |
| MX (2) | MX2016004329A (https=) |
| RU (1) | RU2706729C2 (https=) |
| SG (2) | SG11201601807XA (https=) |
| WO (1) | WO2015057668A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014177459A2 (en) | 2013-04-29 | 2014-11-06 | F. Hoffmann-La Roche Ag | Fc-receptor binding modified asymmetric antibodies and methods of use |
| UA118029C2 (uk) | 2013-04-29 | 2018-11-12 | Ф. Хоффманн-Ля Рош Аг | Модифіковане антитіло, що зв'язується з людським fcrn, й способи його застосування |
| MX380658B (es) | 2014-01-15 | 2025-03-11 | Hoffmann La Roche | Variantes de region fc con union mejorada de la proteina a. |
| AU2016272399B2 (en) | 2015-06-01 | 2021-09-09 | Kyowa Kirin Co., Ltd. | Therapeutic agent and therapeutic method for pulmonary hypertension |
| CN109544378B (zh) * | 2018-10-27 | 2024-06-25 | 平安医疗健康管理股份有限公司 | 一种肺源性心脏病资质认证方法、设备及服务器 |
| TW202110479A (zh) * | 2019-05-16 | 2021-03-16 | 瑞典商阿斯特捷利康公司 | 使用貝那利珠單抗治療增強型患者群體慢性阻塞性肺病之方法 |
| AU2020398168A1 (en) * | 2019-12-06 | 2022-07-28 | Regeneron Pharmaceuticals, Inc. | Methods for treating COPD by administering an IL-33 antagonist |
| EP3957308A1 (en) * | 2020-08-21 | 2022-02-23 | Palobiofarma, S.L. | (1r,3s)-3-((5-cyano-4-phenylthiazol-2-yl)carbamoyl)cyclopentane-1-carboxylic acid and derivatives thereof for use in the treatment of airway diseases |
| CA3223191A1 (en) * | 2021-09-03 | 2023-03-09 | University Of Utah Research Foundation | Compositions and methods for diagnosing, detecting and treating eosinophil-related diseases |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2233974T3 (es) * | 1995-09-11 | 2005-06-16 | Kyowa Hakko Kogyo Co., Ltd. | Anticuerpo contra la cadena alfa del receptor de la interleucina 5 humana. |
| CA2704600C (en) * | 1999-04-09 | 2016-10-25 | Kyowa Kirin Co., Ltd. | A method for producing antibodies with increased adcc activity |
| US7404953B2 (en) * | 2000-02-15 | 2008-07-29 | Kyowa Hakko Kogyo Co., Ltd. | Methods using eosinophil-specific apoptosis inducer |
| US6946292B2 (en) * | 2000-10-06 | 2005-09-20 | Kyowa Hakko Kogyo Co., Ltd. | Cells producing antibody compositions with increased antibody dependent cytotoxic activity |
| US7662925B2 (en) * | 2002-03-01 | 2010-02-16 | Xencor, Inc. | Optimized Fc variants and methods for their generation |
| US20060014680A1 (en) * | 2004-07-13 | 2006-01-19 | Caiding Xu | Peptides and compounds that bind to the IL-5 receptor |
| MX376656B (es) * | 2007-05-14 | 2025-03-07 | Kyowa Kirin Co Ltd | Metodos para reducir niveles de basófilos. |
| CN101249093A (zh) * | 2008-03-19 | 2008-08-27 | 李虎山 | 一种治疗慢性阻塞性肺部疾病的组合物 |
| WO2012049278A1 (en) * | 2010-10-15 | 2012-04-19 | Medimmune Limited | Therapies for improving pulmonary function |
| RU2578468C2 (ru) * | 2010-12-16 | 2016-03-27 | Дженентек, Инк. | Способы диагностики и лечения, связанные с ингибированием th2 |
| WO2012158954A1 (en) * | 2011-05-18 | 2012-11-22 | Medimmune, Llc | Methods of diagnosing and treating pulmonary diseases or disorders |
| US20140328839A1 (en) * | 2011-11-01 | 2014-11-06 | Medlmmune, Llc | Methods For Reducing The Frequency And Severity Of Acute Exacerbations Of Asthma |
| AU2014306956B2 (en) * | 2013-08-12 | 2019-11-21 | Astrazeneca Ab | Methods for reducing exacerbation rates of asthma using benralizumab |
| RU2728578C2 (ru) * | 2013-08-12 | 2020-07-30 | Астразенека Аб | Способы нормализации симптомов астмы с применением бенрализумаба |
| SMT202100152T1 (it) * | 2013-08-12 | 2021-05-07 | Astrazeneca Ab | Metodi per aumentare il volume espiratorio forzato negli asmatici utilizzando benralizumab |
-
2014
- 2014-10-14 WO PCT/US2014/060432 patent/WO2015057668A1/en not_active Ceased
- 2014-10-14 SG SG11201601807XA patent/SG11201601807XA/en unknown
- 2014-10-14 RU RU2016118425A patent/RU2706729C2/ru active
- 2014-10-14 MX MX2016004329A patent/MX2016004329A/es unknown
- 2014-10-14 BR BR112016008082A patent/BR112016008082A2/pt not_active Application Discontinuation
- 2014-10-14 CN CN201480056549.0A patent/CN105636607A/zh active Pending
- 2014-10-14 CA CA2925402A patent/CA2925402A1/en not_active Abandoned
- 2014-10-14 EP EP18189626.7A patent/EP3485902A1/en not_active Withdrawn
- 2014-10-14 JP JP2016523209A patent/JP2016534996A/ja active Pending
- 2014-10-14 EP EP14853201.3A patent/EP3057609A4/en not_active Withdrawn
- 2014-10-14 CN CN202110508239.XA patent/CN113230399A/zh active Pending
- 2014-10-14 AU AU2014334563A patent/AU2014334563A1/en not_active Abandoned
- 2014-10-14 US US14/513,866 patent/US20150104447A1/en not_active Abandoned
- 2014-10-14 KR KR1020167009675A patent/KR20160061352A/ko not_active Ceased
- 2014-10-14 SG SG10201807318RA patent/SG10201807318RA/en unknown
-
2016
- 2016-04-04 MX MX2019013468A patent/MX2019013468A/es unknown
- 2016-05-31 US US15/168,711 patent/US20170107291A1/en not_active Abandoned
-
2017
- 2017-11-29 US US15/825,526 patent/US20180291108A1/en not_active Abandoned
-
2019
- 2019-05-24 US US16/422,212 patent/US20200123262A1/en not_active Abandoned
- 2019-07-18 JP JP2019132432A patent/JP6870037B2/ja active Active
-
2020
- 2020-04-02 AU AU2020202333A patent/AU2020202333A1/en not_active Abandoned
-
2021
- 2021-04-14 JP JP2021068065A patent/JP2021107421A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| SG10201807318RA (en) | 2018-09-27 |
| AU2020202333A1 (en) | 2020-04-23 |
| CA2925402A1 (en) | 2015-04-23 |
| EP3485902A1 (en) | 2019-05-22 |
| MX2016004329A (es) | 2016-11-10 |
| BR112016008082A2 (pt) | 2017-10-17 |
| US20170107291A1 (en) | 2017-04-20 |
| WO2015057668A1 (en) | 2015-04-23 |
| JP2016534996A (ja) | 2016-11-10 |
| CN105636607A (zh) | 2016-06-01 |
| US20150104447A1 (en) | 2015-04-16 |
| MX2019013468A (es) | 2020-02-12 |
| RU2016118425A (ru) | 2017-11-21 |
| JP6870037B2 (ja) | 2021-05-12 |
| JP2019203009A (ja) | 2019-11-28 |
| RU2706729C2 (ru) | 2019-11-20 |
| EP3057609A1 (en) | 2016-08-24 |
| AU2014334563A1 (en) | 2016-04-07 |
| EP3057609A4 (en) | 2017-03-22 |
| US20200123262A1 (en) | 2020-04-23 |
| KR20160061352A (ko) | 2016-05-31 |
| RU2016118425A3 (https=) | 2018-07-19 |
| JP2021107421A (ja) | 2021-07-29 |
| CN113230399A (zh) | 2021-08-10 |
| US20180291108A1 (en) | 2018-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL292193A (en) | Anti-b7–h1 antibodies for the treatment of tumors | |
| IL245193A0 (en) | Thoracoscopic methods for the treatment of bronchial disease | |
| SG11201601807XA (en) | Methods for treating chronic obstructive pulmonary disease using benralizumab | |
| IL243976A0 (en) | kdm1a inhibitors for disease treatment | |
| SG11201600918PA (en) | Method for authenticating transactions | |
| ZA201506401B (en) | Process for producing hydrocarbons | |
| SG11201508388YA (en) | Methods for enhancing aged muscle regeneration | |
| PL3019577T3 (pl) | Sposób wytwarzania węglowodorów | |
| SG11201603050TA (en) | Methods for treating cancers | |
| SG11201507496UA (en) | N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases | |
| IL244042A0 (en) | A method for treating leiftic disease | |
| IL244118A0 (en) | Compounds and methods for the treatment of chronic urticaria | |
| PT3164394T (pt) | Inibidores gls1 para o tratamento de doenças | |
| EP2945593A4 (en) | METHOD OF LYOPHILIZATION | |
| SG11201600484TA (en) | Methods for improving asthma symptoms using benralizumab | |
| LT3016682T (lt) | Vėžio gydymo būdai | |
| PL2875049T3 (pl) | Sposoby zapobiegania i leczenia przewlekłej choroby nerek (ckd) | |
| IL253325A0 (en) | Combined treatment of pulmonary hypertension | |
| TWI563128B (en) | Methods for treating aluminum surfaces | |
| GB201217330D0 (en) | Therapeutic for treating inflammatory lung disorders | |
| LU92599B1 (en) | Oral suspension for treating eosinophilic esophagitis | |
| IL233568A0 (en) | A method for treating obstructive lung disease | |
| HK1227729A1 (en) | Methods for treating chronic obstructive pulmonary disease using benralizumab | |
| LU92721B1 (en) | Oral suspension for treating eosinophilic esophagitis | |
| GB201304811D0 (en) | Novel treatment for hypertension |